Preferences help
enabled [disable] Abstract
Number of results
2002 | 49 | 1 | 269-273
Article title

Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients.

Title variants
Languages of publication
Patients with colorectal carcinoma showed statistically significant lower values of transferrin saturation, total iron binding capacity and serum iron level as compared with control group, while the level of ferritin and the size of labile iron pool in carcinoma patients were higher, although this difference was not statistically significant. Our observations are in favour of the hypothesis which suggests that changes in iron metabolism restrict iron availability for tumour cells and as consequence, slow their growth.
Physical description
  • Department of Clinical Biochemistry, Medical University in Bydgoszcz, Bydgoszcz, Poland
  • Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Department of Experimental Hematology and Cord Blood Bank, Warszawa, Poland
  • Department and Clinic of Surgery, Ludwik Rydygier, Medical University in Bydgoszcz, Bydgoszcz, Poland
  • Department and Clinic of Surgery, Ludwik Rydygier, Medical University in Bydgoszcz, Bydgoszcz, Poland
  • Department of Clinical Biochemistry, Medical University in Bydgoszcz, Bydgoszcz, Poland
  • 1. Halliwell, B.M. & Gutterige, J.M.C. (1999) Free Radicals in Biology and Medicine; 3rd edn. Oxford University Press Inc., New York.
  • 2. Stevens, G., Graubard, B.I., Micozzi, M.S., Neriishi, K. & Blumberg, B.S. (1994) Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer. 56, 364-369.
  • 3. Nelson, R.L., Davis, F.G., Sutter, E., Sobin, L.H., Kikendall, J.W. & Bowen, P. (1994) Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86, 455-460.
  • 4. Bird, C.L., Witte, J.S., Swendseid, M.E., Shikany, J.M., Hunt, I.F., Frankl, H.D., Lee, E.R, Longnecker, M.P. & Haile, R.W. (1996) Plasma ferritin, iron intake, and the risk of colorectal polyps. Am. J. Epidemiol. 144, 34-41.
  • 5. Schmielau, J. & Finn, O.J. (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanisms of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760.
  • 6. Gackowski, D., Ciecierski, M., Jawien, A. & Olinski, R. (2001) Background level of 8-oxo-2'-deoxyguanosine in lymphocyte DNA does not correlate with concentration of antioxidant vitamins in blood plasma. Acta Biochim. Polon. 48, 535-539.
  • 7. Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W. & Cabantchik, I. (1997) Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248, 31-40.
  • 8. Lipinski, P., Drapier, J.-C., Oliveira, L., Retmanska, H., Sochanowicz, B. & Kruszewski, M. (2000) Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: A study of L5178Y mouse lymphoma cell lines differentially sensitive to H2O2. Blood. 95, 2960-2966.
  • 9. Stevens, R.G., Jones, D.Y., Micozzi, M.S. & Taylor, P.R. (1998) Body iron stores and the risk of cancer. N. Engl. J. Med. 319, 1047-1052.
  • 10. Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliovaara, M. & Hakulinen, T. (1994) Body iron stores and risk of cancer. Int. J. Cancer 56, 379-382.
  • 11. Bendich, A. & Cohen, M. (1990) Ascorbic acid safety: Analysis of factors affecting iron absorption. Toxicol. Lett. 51, 189-201.
  • 12. Hallberg, L., Hulten, L. & Gramatkovski, E. (1997) Iron absorption from the whole diet in men: How effective is the regulation of iron absorption? Am. J. Clin. Nutr. 66, 347-356.
  • 13. Ponka, P. (2000) Iron metabolism: Physiology and pathophysiology. J. Trace Elem. Exp. Med. 13, 73-93.
  • 14. Weinberg, E.D. (1996) The role of iron in cancer. Eur. J. Cancer Prevent. 5, 19-36.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.